Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation

Blood

Volumn 100, Issue 13, 2002, Pages 4660-4667

  BitMansour, Andrew ^a   Burns, Stacy M ^a   Traver, David ^a   Akashi, Koichi ^a   Contag, Christopher H ^a   Weissman, Irving L ^a   Brown, Janice M Y ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GR 1 ANTIBODY; LUCIFERASE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BACTERIAL STRAIN; BACTERIUM CULTURE; BIOLUMINESCENCE; BONE MARROW CELL; CELL COUNT; CELL DEATH; CELL LINEAGE; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ENGINEERING; FUNGUS CULTURE; GRAM NEGATIVE INFECTION; GRANULOCYTE PRECURSOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LETHALITY; MONOCYTE; MOUSE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; SPLEEN; SURVIVAL; TREATMENT OUTCOME;

EID: 0037114640     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-05-1552     Document Type: Article

References (41)

1. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 1999;12:310-350.
2. Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998;26:781-803; quiz 804-805.
3. Malech HL, Gallin JI. Current concepts: Immunology: Neutrophils in human diseases. N Engl J Med. 1987;317:687-694.
4. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Prolonged granulocytopenia: The major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med. 1984;100:345-351.
5. Morrison AJ Jr, Wenzel RP. Epidemiology of infections due to Pseudomonas aeruginosa. Rev Infect Dis. 1984;6(suppl 3):S627-S642.
6. Ehni WF, Reller LB, Ellison RT III. Bacteremia in granulocytopenic patients in a tertiary-care general hospital. Rev Infect Dis. 1991;13:613-619.
7. Young LS, Armstrong D. Human immunity to Pseudomonas aeruginosa, I: In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors. J Infect Dis. 1972;126:257-276.
8. Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest. 1982;69:617-631.
9. Crawford J, Ozer H, et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med. 1991;325:164-170.
10. Nemunaitis J. A comparative review of colony-stimulating factors. Drugs. 1997;54:709-729.
11. Lifton R, Bennett JM. Clinical use of granulocytemacrophage colony-stimulating factor and granulocyte colony-stimulating factor in neutropenia associated with malignancy. Hematol Oncol Clin North Am. 1996;10:825-839.
12. Nemunaltis J, Rosenfeld CS, Ash R, et al. Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation. Bone Marrow Transplant. 1995;15:949-954.
13. Antman KS, Griffin JD, Elias A, et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med. 1988;319:593-598.
14. Rowe JM, Andersen JW, Mazza JJ, et al. A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: A study of the Eastern Cooperative Oncology Group (E1490). Blood. 1995;86:457-462.
15. Andriole VT, Miniter P, George D, Kordick D, Patterson TF. Animal models: Usefulness for studies of fungal pathogenesis and drug efficacy in aspergillosis. Clin Infect Dis. 1992;14(suppl 1):S134-S138.
16. Peters C, Minkov M, Matthes-Martin S, et al. Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients. Br J Haematol. 1999;106:689-696.
17. Strauss RG, Connett JE, Gale RP, et al. A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med. 1981;305:597-603.
18. Young LS. Prophylactic granulocytes in the neutropenic host. Ann Intern Med. 1982;96:240-242.
19. Lagasse E, Weissman IL. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell. 1997;89:1021-1031.
20. Hubel K, Dale DC, Engert A, Liles WC. Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases. J Infect Dis. 2001;183:321-328.
21. Dixon DM, Polak A, Walsh TJ. Fungus dose-dependent primary pulmonary aspergillosis in immunosuppressed mice. Infect Immun. 1989;57:1452-1456.
22. Kondo M, Weissman IL, Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 1997;91:661-672.
23. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404:193-197.
24. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science. 1988;241:58-62.
25. Uchida N, Tsukamoto A, He D, Friera AM, Scollay R, Weissman IL. High doses of purified stem cells cause early hematopoietic recovery in syngeneic and allogeneic hosts. J Clin Invest. 1998;101:961-966.
26. Rosenthal SM. Chemotherapy of Pseudomonas septicemia in burned mice. Ann N Y Acad Sci. 1968;150:931-936.
27. Rosenthal SM. Local and systemic therapy of pseudomonas septicemia in burned mice. Ann Surg. 1967;165:97-103.
28. Winson MK, Swift S, Hill PJ, et al. Engineering the luxCDABE genes from Photorhabdus luminescens to provide a bioluminescent reporter for constitutive and promoter probe plasmids and mini-Tn5 constructs. FEMS Microbiol Lett. 1998;163:193-202.
29. Olsen RH, DeBusscher G, McCombie WR. Development of broad-host-range vectors and gene banks: Self-cloning of the Pseudomonas aeruginosa PAO chromosome. J Bacteriol. 1982;150:60-69.
30. Contag PR, Olomu IN, Stevenson DK, Contag CH. Bioluminescent indicators in living mammals. Nat Med. 1998;4:245-247.
31. Contag CH, Spilman SD, Contag PR, et al. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol. 1997;66:523-531.
32. Contag CH, Contag PR, Mullins JI, Spilman SD, Stevenson DK, Benaron DA. Photonic detection of bacterial pathogens in living hosts. Mol Microbiol. 1995;18:593-603.
33. Lagasse E, Weissman IL. Flow cytometric identification of murine neutrophils and monocytes. J Immunol Methods. 1996;197:139-150.
34. Tepper RI, Coffman RL, Leder P. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science. 1992;257:548-551.
35. Czuprynski CJ, Brown JF, Maroushek N, Wagner RD, Steinberg H. Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J Immunol. 1994;152:1836-1846.
36. Rakhmilevich AL. Neutrophils are essential for resolution of primary and secondary infection with Listeria monocytogenes. J Leukoc Biol. 1995;57:827-831.
37. Roberts AW, Metcalf D. Granulocyte colony-stimulating factor induces selective elevations of progenitor cells in the peripheral blood of mice. Exp Hematol. 1994;22:1156-1163.
38. Gaviria JM, van Burik JA Dale DC, Root RK, Liles WC. Comparison of interferon-γ, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens. J Infect Dis. 1999;179:1038-1041.
39. Ward AC, Smith L, de Koning JP, van Aesch Y, Touw IP. Multiple signals mediate proliferation, differentiation, and survival from the granulocyte colony-stimulating factor receptor in myeloid 32D cells. J Biol Chem. 1999;274:14956-14962.
40. Dale DC, Liles WC, Price TH. Renewed interest in granulocyte transfusion therapy. Br J Haematol. 1997;98:497-501.
41. Ojeda E, Garcia-Bustos J, Aguado M, et al. A prospective randomized trial of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in adults. Bone Marrow Transplant. 1999;24:601-607.